Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
OCDX was delisted on the 26th of May, 2022.
106 hedge funds and large institutions have $4.95B invested in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 16 closing their positions.
55,957% more call options, than puts
Call options by funds: $7.85M | Put options by funds: $14K
75% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 16
12% more funds holding
Funds holding: 95 → 106 (+11)
10% more capital invested
Capital invested by funds: $4.52B → $4.95B (+$436M)
0% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 36
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$29.8M |
| 2 |
SCM
Shapiro Capital Management
Atlanta,
Georgia
|
+$29.6M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$27.2M |
| 4 |
State Street
Boston,
Massachusetts
|
+$17.4M |
| 5 |
Millennium Management
New York
|
+$17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$45.7M |
| 2 |
DM
Deerfield Management
New York
|
-$45.4M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$14.7M |
| 4 |
AC
Armistice Capital
New York
|
-$10.7M |
| 5 |
Goldman Sachs
New York
|
-$9.78M |
OCDX Hedge Fund Activity: Q2 2021 in Review
106 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) for Q2 2021, worth a combined $4.95B — up 9.6% from $4.52B a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new OCDX positions and 16 closed out — a net gain of 12 holders — while 36 added to existing stakes and 36 trimmed.
The largest buyer was Macquarie Group, opening a new position worth an estimated $29.8M. The largest seller was Alyeska Investment Group, cutting an estimated $45.7M.
- 106 institutional investors held Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) as of Q2 2021, up from 95 in Q1 2021.
- Funds reported $4.95B of Ortho Clinical Diagnostics Holdings plc Ordinary Shares stock for Q2 2021, up 9.6% quarter-over-quarter.
- 28 funds opened new Ortho Clinical Diagnostics Holdings plc Ordinary Shares positions in Q2 2021 and 16 closed out, a net change of +12 holders.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares buyer in Q2 2021 was Macquarie Group, an estimated $29.8M added.
- The largest Ortho Clinical Diagnostics Holdings plc Ordinary Shares seller in Q2 2021 was Alyeska Investment Group, an estimated $45.7M sold.
Based on aggregated 13F filings for Q2 2021.